PubMed:10478664 / 155-345
Annnotations
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 105-108 | PR:Q9VE87 | denotes | HMW |
| T12 | 110-121 | D007633 | denotes | cytokeratin |
| T13 | 152-158 | UBERON:0000310 | denotes | breast |
| T14 | 172-178 | UBERON:0000310 | denotes | breast |
| T15 | 172-189 | D001943 | denotes | breast carcinomas |
| T16 | 172-189 | D001943 | denotes | breast carcinomas |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 172-189 | HP_0003002 | denotes | breast carcinomas |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 0-190 | DRI_Background | denotes | A variety of studies have investigated the role of low molecular weight (LMW) and high molecular weight (HMW) cytokeratin (CK) expression in the normal breast and invasive breast carcinomas. |